TRX-585

N/A

Report date: 2024/12/04 15:17:57

Base Information

Drug NameTRX-585
Drug Alias NameTRX-585
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Leukocyte immunoglobulin-like receptor subfamily B member 3
TargetsLeukocyte immunoglobulin-like receptor subfamily B member 3
Therapy Area/IndicationsNeoplasmsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTolerx
China Registration ClassN/A

Develop Information

Active CompaniesTolerx
Inactive CompaniesN/A
Active IndicationsNeoplasmsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A